234 results on '"Guarino, D."'
Search Results
2. Different Treatments in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Strategies in the Italian Centre Real-world Experience
3. Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension
4. Analysis of prognostic predictors and differences between subgroups of pulmonary arterial hypertension associated with portal hypertension and HIV infection
5. Predicting In-Hospital Acute Heart Failure Worsening in the Oldest Old: Insights from Point-of-Care Ultrasound
6. Utility of lung ultrasound in selecting older patients with hyperinflammatory phase in COVID-19 pneumonia. A monocentric, cross-sectional pilot study
7. Discontinuation of Loop Diuretics in Older Patients with Chronic Stable Heart Failure: A Narrative Review
8. Predicting mortality and re-hospitalization for heart failure: a machine-learning and cluster analysis on frailty and comorbidity
9. Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort
10. Advancing healthcare through thoracic ultrasound research in older patients
11. A clinical and echocardiographic score to differentiate pulmonary hypertension due to heart failure with preserved ejection fraction from idiopathic pulmonary hypertension: the PH-HFPEF score
12. Dabigatran-induced acute liver injury in older patients: Case report and literature review
13. IDENTIFICATION OF RADIAL VASCULAR WALL ABNORMALITIES BY VERY-HIGH FREQUENCY ULTRASOUND IN FIBROMUSCULAR DYSPLASIA AND SPONTANEOUS CORONARY ARTERY DISSECTION: THE FUCHSIA STUDY
14. PROGNOSTIC ROLE OF COMORBIDITIES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
15. SHORT-TERM EFFECT OF SELEXIPAG IN COMPARISON TO PROSTACYCLIN ANALOGUES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION STARTED ON DOUBLE-COMBINATION THERAPY WITH ERA AND PDE-5 INHIBITORS
16. SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION LISTED FOR LUNG TRANSPLANTATION
17. EXPERIENCE OF FIVE YEARS OF BALLOON PULMONARY ANGIOPLASTY IN A SINGLE CENTER: SAFETY AND SHORT TERM RESULTS
18. ROLE OF CARDIAC MAGNETIC RESONANCE IN STRATIFYING THE PROGNOSIS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
19. A CLINICAL AND ECHOCARDIOGRAPHIC SCORE TO DIFFERENTIATE PULMONARY HYPERTENSION DUE TO HEART FAILURE WITH PRESERVED EJECTION FRACTION FROM IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION: THE PH-HFPEF SCORE
20. PROGNOSTIC VALUE OF PULMONARY ARTERY DIAMETER IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
21. PROGNOSTIC STRATIFICATION ROLE OF STROKE VOLUME INDEX IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AT INTERMEDIATE RISK
22. Pneumonia Lung Ultrasound Score (PLUS): A New Tool for Detecting Pneumonia in the Oldest Patients
23. Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles
24. L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia
25. Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation
26. Role of cardiac magnetic resonance in stratifying the prognosis of patients with pulmonary arterial hypertension
27. Echocardiographic predictors of low risk haemodynamic parameters in patients with pulmonary arterial hypertension
28. Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients
29. Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Mechanisms of Diabetes Remission and Role of Gut Hormones
30. Prognostic role of comorbidities in patients with pulmonary arterial hypertension
31. Prognostic value of pulmonary artery diameter in patients with pulmonary arterial hypertension
32. Short term effect of Selexipag in comparison to parenteral prostacyclin analogues in pulmonary arterial hypertension patients started on double-combination therapy with ERA and PDE-5 inhibitors
33. Additional role of echocardiogram in pulmonary arterial hypertension risk stratification according to current ESC/ERS guidelines
34. The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery
35. Prognostic Value of Pulmonary Artery Diameter in Patients with Pulmonary Arterial Hypertension
36. Prognostic Value of Stroke Volume Index in Patients with Pulmonary Arterial Hypertension at Intermediate Risk
37. Prognostic Role of Laboratory Parameters in Patients with Pulmonary Arterial Hypertension
38. Prognostic Role of Comorbidities in Patients with Pulmonary Arterial Hypertension
39. Short Term Effect of Selexipag in Comparison to Prostacyclin Analogues in Pulmonary Arterial Hypertension Patients Started on Double-Combination Therapy with ERA and PDE-5 Inhibitors
40. P4.7 Relationship of Different Cardiovascular Tissue Biomarkers with Established Risk Factors and Framingham Risk Score in Middle-Age Subjects without Cardiovascular Events
41. Post-prandial hypoglycaemia after Roux en-Y gastric bypass: Could Neuromedin U play a role in the pathogenesis?
42. Virtual Reality environments to reduce dental anxiety
43. P4680Prognostic value of stroke volume index in patients with pulmonary arterial hypertension at intermediate risk
44. P4688Additional role of unmodifiable risk factors in pulmonary arterial hypertension risk stratification according to current ESC/ERS guidelines
45. P4676Experience of three years of balloon pulmonary angioplasty in a single centre: safety and short term results
46. ARTERIAL STIFFNESS AND REMODELING FROM LARGE TO SMALL ARTERIES IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION
47. P460The role of cardiac magnetic resonance in cardiac masses: a single centre experience
48. Effect of Pulmonary Arterial Hypertension Specific Therapy in the Four Clinical Subgroups of Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
49. A Pragmatic Approach to Risk Assessment in Pulmonary Arterial Hypertension Using the ESC/ERS Guidelines
50. Additional Role of Unmodifiable Risk Factors in Pulmonary Arterial Hypertension Risk Stratification According to Current ESC/ERS Guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.